Now accepting patients in South Florida — Book your free assessment →
Cosmetic & Other

Melanotan II

Also known as: MT-II, MT2, Melanotan-2

A synthetic melanocortin peptide sold online for cosmetic tanning. It is unapproved, unregulated, and linked to serious safety concerns — and Strong Health does not provide it. This page exists to give you the honest facts.

D
Written by
M.D., Staff Psychiatrist · Medical Reviewer, Strong Health
D
Medically reviewed by
M.D., Staff Psychiatrist · Medical Reviewer, Strong Health
Published: July 23, 2026 Updated: July 23, 2026 · Editorial Standards

What is Melanotan II?

Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) that stimulates the skin's pigment cells to produce more melanin, darkening the skin. It is sold online and through gray-market channels as an injectable "tanning" peptide, typically self-administered without medical supervision.

It is not an approved medicine. Melanotan II has never been through the clinical development and approval process required of a drug, and it is illegal to sell for human use in many countries. It should not be confused with afamelanotide (SCENESSE), a related but FDA-approved melanocortin implant used only for a rare inherited disorder — nor with PT-141 (bremelanotide), a Melanotan II metabolite developed as an approved treatment for low sexual desire.

How Melanotan II works

Melanin is the skin's natural pigment and its built-in defense against UV damage. Melanotan II is a non-selective agonist at melanocortin receptors: activating the melanocortin-1 receptor (MC1R) on melanocytes drives them to produce more eumelanin, which darkens the skin even with limited sun exposure [1].

Because it also activates other melanocortin receptors — including MC3R and MC4R in the brain — its effects extend well beyond pigmentation. That off-target activity explains why appetite, sexual arousal, and blood pressure can all be affected, and it is the same MC4R action that PT-141 was later developed to exploit deliberately. Critically, a peptide-induced tan does not make UV exposure safe.

What Melanotan II is used for

Cosmetic tanning (unapproved)

The reason Melanotan II is sold: to darken skin with less sun or sunbed time. There is no approved indication for this use, and the products are unregulated.

"Sunless tan" marketing claims

It is often marketed as a safer route to a tan. In reality it offers no reliable UV protection and carries its own distinct risks — the opposite of the safety it is sold on.

Not a treatment we provide

Strong Health does not prescribe or supply Melanotan II. Where pigment or skin concerns are involved, we point patients to dermatology and evidence-based skin care instead.

What the evidence shows

There is no body of large, controlled clinical trials establishing Melanotan II as a safe or effective cosmetic product — it was never developed as an approved drug. What exists instead is a substantial dermatology literature documenting harms in people who use it.

Case reports and case series have described new, changing, and atypical melanocytic naevi (moles) in Melanotan II users, and melanoma diagnosed in the setting of its use [3]. National regulators including the U.S. FDA and the UK's MHRA have issued public warnings against these products.

The one melanocortin peptide with regulatory approval, afamelanotide, is approved only to increase pain-free light exposure in adults with erythropoietic protoporphyria — a narrow, specialist indication that says nothing about the safety of self-injected Melanotan II for a tan [2].

Dosing & administration context

Because Melanotan II is unapproved and unregulated, there is no legitimate medical dosing standard for cosmetic use, and Strong Health does not provide one. Products bought online carry no assurance of identity, purity, sterility, or dose, and are usually self-injected — compounding the risk.

This section is deliberately not a how-to. Our position is that there is no version of self-injected Melanotan II we can stand behind, and we would rather help you protect your skin than tan it pharmacologically.

Melanotan II is not an approved drug. It is unregulated, illegal to sell for human use in many countries, and not provided by Strong Health. This page is educational and is not medical advice or a dosing guide.

Safety & side effects

The most serious concern is the skin itself: reports of new and atypical moles, and of melanoma, in Melanotan II users. Anyone who has used it and notices a new, changing, darkening, or asymmetric mole should see a dermatologist promptly [3].

Systemic side effects are also commonly reported, including nausea, facial flushing, spontaneous erections, appetite changes, and shifts in blood pressure — a direct consequence of the peptide's action on melanocortin receptors beyond the skin. And because a Melanotan tan offers no dependable UV protection, it may encourage more sun or sunbed exposure, adding to skin-cancer risk rather than reducing it.

Common side effects

  • ·New, changing, or atypical moles (naevi) — and melanoma case reports
  • ·Nausea and facial flushing
  • ·Spontaneous erections
  • ·Appetite changes and blood-pressure changes
  • ·Darkening of existing moles and freckles

Who should not use it

  • ·Anyone — Strong Health does not consider self-injected Melanotan II safe for cosmetic use
  • ·A personal or family history of melanoma or atypical moles
  • ·Any new or changing skin lesion (see a dermatologist first)
  • ·Pregnancy or breastfeeding

Why Strong Health does not offer Melanotan II

Strong Health does not prescribe, compound, or supply Melanotan II, and we would not recommend it. We built our practice on physician supervision, pharmacy-grade sourcing, and honest evidence — and an unregulated, self-injected tanning peptide with melanoma case reports fails that standard on every count.

If your underlying interest is skin health and appearance, we are glad to help with approaches that have real support. See our guide to peptides for skin and anti-aging, explore the physician-reviewed molecule library, and — most importantly — treat daily sun protection and prompt dermatology review of any changing mole as the foundation of skin safety.

Interested in skin health, pigment concerns, or evidence-based peptides? Talk to one of our physicians about approaches with real support — or explore our physician-reviewed guides.

Talk to a physician about skin & safety →

See our guide to peptides for skin, the honest picture on peptides for tanning, or browse the molecule library.

Frequently asked questions

Is Melanotan II safe?

No — we would urge real caution. Melanotan II is unregulated and linked to concerning effects, including new and atypical moles and case reports of melanoma, along with nausea, flushing, and blood-pressure changes. Strong Health does not offer it.

Is Melanotan II FDA-approved?

No. Melanotan II is not FDA-approved and is illegal to sell for human use in many countries. Products sold online have no guarantee of purity, sterility, or dose. The only FDA-approved melanocortin peptide, afamelanotide, treats a rare disease — not cosmetic tanning.

How is Melanotan II different from PT-141?

PT-141 (bremelanotide) is a metabolite of Melanotan II that was developed specifically for sexual desire and is FDA-approved as Vyleesi for that use in premenopausal women. Melanotan II itself is the unapproved tanning peptide and is a different product with different, unregulated risks.

Does a Melanotan tan protect me from the sun?

No. A melanocortin-induced tan does not make UV exposure safe and may encourage more sun or sunbed use. Melanin offers only limited protection, and the peptide raises its own distinct safety concerns.

Does Strong Health offer Melanotan II?

No. We do not provide Melanotan II or any peptide for cosmetic tanning. If your interest is skin health, we're happy to discuss approaches with real evidence and to point you toward dermatology care for any concerns about moles or skin lesions.

References & sources

  1. [1] Langan EA, Nie Z, Rhodes LE. Melanotropic peptides: what does the future hold? A review of afamelanotide and related melanocortin agonists. British Journal of Dermatology. 2010. View source →
  2. [2] U.S. Food and Drug Administration. SCENESSE (afamelanotide) — approval to increase pain-free light exposure in adults with erythropoietic protoporphyria. FDA, 2019. View source →
  3. [3] Published dermatology case reports have described new and atypical melanocytic naevi, and melanoma, in users of Melanotan II; national regulators (FDA, MHRA) have issued safety warnings against these products.

Related molecules

Browse all molecules →